Gestion du risque thromboembolique veineux en chirurgie carcinologique

The incidence of venous thrombo-embolic events after cancer surgery remains high. Their prevention is based on early mobilization and walking combined with heparin at a preventive dosing and for a long time (4 weeks). Dalteparin and enoxaparin, two low-molecularweight heparins, are fist-line treatment due to their efficacy, safety and maniability.